Till Braunschweig
Overview
Explore the profile of Till Braunschweig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meurer S, Bronneberg G, Penners C, Kauffmann M, Braunschweig T, Liedtke C, et al.
Cell Commun Signal
. 2025 Feb;
23(1):76.
PMID: 39934802
Mast cells develop from the myeloid lineage and are released from the bone marrow as immature cells, which then differentiate at the destination tissue based on cues from the local...
2.
Braunschweig T, Schierle K
Pathologie (Heidelb)
. 2024 Aug;
45(Suppl 1):97-99.
PMID: 39207567
No abstract available.
3.
Liokatis P, Liokati I, Obermeier K, Smolka W, Ersan F, Dewenter I, et al.
Oral Oncol
. 2024 Jun;
154:106808.
PMID: 38823172
Background: An estimated 20% of patients with oral and oropharyngeal squamous cell carcinoma (OOSCC) have micrometastases (Mi) or isolated tumor cells (ITC) in the cervical lymph nodes that evade detection...
4.
Raufeisen J, Xie K, Horst F, Braunschweig T, Li J, Kleesiek J, et al.
Comput Methods Programs Biomed
. 2024 May;
252:108215.
PMID: 38781811
Background And Objective: Cell segmentation in bright-field histological slides is a crucial topic in medical image analysis. Having access to accurate segmentation allows researchers to examine the relationship between cellular...
5.
Becker A, Puladi B, Xie K, Cassataro A, Gotzl R, Holzle F, et al.
World J Surg Oncol
. 2024 May;
22(1):131.
PMID: 38760830
Background: Liposarcomas are among the most common mesenchymal malignancies. However, the therapeutic options are still very limited and so far, targeted therapies had not yet been established. Immunotherapy, which has...
6.
Melchior C, Isfort P, Braunschweig T, Witjes M, Van den Bosch V, Rashad A, et al.
BMC Med Educ
. 2024 Mar;
24(1):250.
PMID: 38500112
Objective: The gold standard of oral cancer (OC) treatment is diagnostic confirmation by biopsy followed by surgical treatment. However, studies have shown that dentists have difficulty performing biopsies, dental students...
7.
Hempel P, Klein V, Michely A, Boll S, Rieg A, Spillner J, et al.
Respir Res
. 2023 Nov;
24(1):262.
PMID: 37907918
Introduction: The standard therapy for bronchial asthma consists of combinations of acute (short-acting ß-sympathomimetics) and, depending on the severity of disease, additional long-term treatment (including inhaled glucocorticoids, long-acting ß-sympathomimetics, anticholinergics,...
8.
Makowska A, Wahab L, Braunschweig T, Kapetanakis N, Vokuhl C, Denecke B, et al.
Oncotarget
. 2023 Aug;
14:782-787.
PMID: 37646784
No abstract available.
9.
Rayatdoost F, Braunschweig T, Schochl H, Rossaint R, Grottke O
Thromb Haemost
. 2023 Aug;
124(1):20-31.
PMID: 37604188
Background: Andexanet alfa (andexanet) is a reversal agent for use in patients with life-threatening or uncontrolled bleeding treated with oral factor Xa (FXa) inhibitors. There are limited data on the...
10.
Mechelinck M, Hein M, Kupp C, Braunschweig T, Helmedag M, Klinkenberg A, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511114
The effect of liver cirrhosis on vascular remodeling in vivo remains unknown. Therefore, this study investigates the influence of cholestatic liver cirrhosis on carotid arterial remodeling. A total of 79...